Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report

BACKGROUND: Rebiopsy is highly recommended to identify the mechanism of acquired resistance to EGFR-TKIs in advanced lung cancer. Recent advances in multiplex genotyping based on circulating tumor DNA (ctDNA) provide a strong and non-invasive alternative for detection of the resistance mechanism. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenhua, He, Qihua, Chen, Ying, Chuai, Shaokun, Yin, Weiqiang, Wang, Wei, Peng, Guilin, Zhou, Caicun, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744376/
https://www.ncbi.nlm.nih.gov/pubmed/26850068
http://dx.doi.org/10.1186/s12885-016-2088-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744376/
https://www.ncbi.nlm.nih.gov/pubmed/26850068
http://dx.doi.org/10.1186/s12885-016-2088-5

Ejemplares similares